Skip to main content

Advertisement

Table 3 IL-10 polymorphisms and risk of PCa

From: Association of genetic polymorphisms in the interleukin-10 promoter with risk of prostate cancer in Chinese

Genotype/Allele/haplotype Controls n (%) PCa n (%) P Adjusted OR* (95%CI)
Genotype(-1082A/G)     
   AA 240(88.9) 222(84.7)   1.00
   AG 27(10.0) 36(13.7) 0.141 1.50(0.87~2.57)
   GG 3(1.1) 4(1.5) 0.520 1.68(0.35~8.17)
Allele     
   A 507(93.9) 480(91.6)   1.00
   G 33(6.1) 44(8.4) 0.113 1.48(0.91~2.38)
Genotype(-819 C/T)     
   TT 132(48.9) 120(45.9)   1.00
   TC 110(40.7) 108(41.2) 0.675 1.08(0.75~1.56)
   CC 28(10.4) 34(12.9) 0.296 1.35(0.77~2.36)
Allele     
   T 374(69.3) 348(66.4)   1.00
   C 166(30.7) 176(33.6) 0.309 1.14(0.88~1.48)
Genotype(-592 C/A)     
   AA 132(48.8) 120(45.9)   1.00
   AC 110(40.8) 108(41.2) 0.675 1.08(0.75~1.56)
   CC 28(10.4) 34(12.9) 0.296 1.35(0.77~2.36)
Allele     
   A 374(69.3) 348(66.4)   1.00
   C 166(30.7) 176(33.6) 0.309 1.14(0.88~1.48)
Haplotype     
   ATA 368(68.1) 340(64.9)   1.00
   ACC 139(25.7) 140(26.7) 0.551 1.13(0.86~1.47)
   GTA 6(1.1) 8(1.5) 0.489 1.42(0.56~4.12)
   GCC 27(5.0) 36(6.9) 0.174 1.45(0.86~2.47)
  1. OR*, adjusted for age and smoking status